Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
08/07/2013 | CN103230372A Moxifloxacin hydrochloride freeze-dried powder injection and preparation method thereof |
08/07/2013 | CN103230367A Cefpodoxime proxetil composition dry suspension and preparation method thereof |
08/07/2013 | CN103230364A Preparation method of ceftiofur acid long-acting injection |
08/07/2013 | CN103230363A Antifungal oral solution |
08/07/2013 | CN103230354A Sweating suppression deodorant composition |
08/07/2013 | CN102940615B Erythromycin enteric-coated tablets and preparation method thereof |
08/07/2013 | CN102885850B Porous gel granules for treating vaginitis |
08/07/2013 | CN102875513B Microcrystal catechin and preparation method thereof |
08/07/2013 | CN102764251B Simple and effective medicine for externally treating internal diseases |
08/07/2013 | CN102743571B Preparation method of Chinese medicine irrigation solution for treating smoking type mycotic vaginitis |
08/07/2013 | CN102719365B Paecilomyces lilacinus with bacteriostatic activity |
08/07/2013 | CN102670815B External traditional Chinese medicine for curing beriberi |
08/07/2013 | CN102657602B 3,5-dyhydroxyl-4-isopropyl diphenylethene chitosan gel and preparation method thereof |
08/07/2013 | CN102657594B Application of toad peptide antibiotics in toothpaste preparation |
08/07/2013 | CN102631666B Preparation method for biological agent for preventing and controlling human papilloma virus infection |
08/07/2013 | CN102631550B Method for preparing traditional Chinese medicine (TCM) lotion for treating pus type pustule on sole |
08/07/2013 | CN102626499B Traditional Chinese medicinal composition used as both food and medicine for treating porcine respiratory tract infection, and preparation method thereof |
08/07/2013 | CN102584671B Bis-Schiff bases synthesized by condensing indole-3-carboxaldehyde and benzidine and preparation method thereof |
08/07/2013 | CN102552898B Purification preparation method of human rotavirus inactivated vaccines by utilizing ion exchange chromatography |
08/07/2013 | CN102552540B Traditional Chinese medicine composition for enhancing immunity and preparation method thereof |
08/07/2013 | CN102525978B Children amoxicillin-potassium clavulanate composition |
08/07/2013 | CN102512532B Medicine composition for preventing and treating diseases of quail |
08/07/2013 | CN102499909B Itraconazole dispersible tablets and preparation method thereof |
08/07/2013 | CN102488828B Chinese medicinal composition for treating infectious bronchitis and its preparation method |
08/07/2013 | CN102485254B Traditional Chinese medicine composition with characteristics of clearing heat and detoxifying, cooling blood and freeing strangury as well as its preparation method |
08/07/2013 | CN102429906B Use of nitrogen heterocyclic compound in preparing drug for inhibiting toxicity of amyloid polypeptide |
08/07/2013 | CN102389500B Heat clearing and detoxifying oral solution |
08/07/2013 | CN102382073B Rupestonic acid isoxazole amides derivative, preparation method and application thereof |
08/07/2013 | CN102380094B Application of specific polypeptide to preparation of rabies vaccine |
08/07/2013 | CN102286045B Roxithromycin monohydrate crystal, preparation method thereof and compound dry suspension containing roxithromycin monohydrate crystal and ambroxol hydrochloride composition |
08/07/2013 | CN102276630B Cefminox sodium crystalline compound and composition powder injection thereof |
08/07/2013 | CN102101857B 1-(4-chlorine-2H-benzo[b]thiapyran-3-formaldehyde) (thio)semicarbazone derivative serving as antifungal agent |
08/07/2013 | CN102091329B Preparation method of inactivated porcine parvovirus vaccine and product thereof |
08/07/2013 | CN101955478B Preparation of brominated flavanonollignan and application in medicine for treating viral hepatitis B |
08/07/2013 | CN101880282B Purification method of pyrrolidine carbapenem antibiotics |
08/07/2013 | CN101798565B Bacillus anthracis capable of showing PA20 protein on surface of spore and application thereof |
08/07/2013 | CN101745102B Composition of 5-aminolevulinic acid and derivative thereof as well as application thereof |
08/07/2013 | CN101711237B Azapeptide derivatives |
08/07/2013 | CN101594869B Thioxanthene derivates useful to treat infectious diseases |
08/07/2013 | CN101563100B Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
08/07/2013 | CN101386606B 3-amino-7-dialkylamide substituted phenothiazines compounds and preparation method and use thereof |
08/07/2013 | CN101379089B Anti-ilt7 antibody |
08/07/2013 | CN101378781B Compositions and methods for production of immunoglobulins |
08/06/2013 | US8502014 Method for the production of a single heavy chain antibody |
08/06/2013 | US8501791 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
08/06/2013 | US8501774 Oxazolidinone-quinolone hybrid antibiotics |
08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
08/06/2013 | US8501717 Methods to treat and/or prevent mucositis |
08/06/2013 | US8501240 Compositions comprising an active agent |
08/06/2013 | US8501171 Use of ADCC-optimized antibodies for treating weak patients |
08/06/2013 | CA2844264A1 Optimized antigens of pneumocystis and use thereof |
08/06/2013 | CA2689696C Microemulsions with adsorbed macromolecules and microparticles |
08/06/2013 | CA2654945C Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
08/06/2013 | CA2598684C Porcine helicobacter infection |
08/06/2013 | CA2563180C Non-nucleoside reverse transcriptase inhibitors |
08/06/2013 | CA2557304C Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
08/06/2013 | CA2529949C Antiviral compounds and methods |
08/06/2013 | CA2519429C Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
08/06/2013 | CA2458016C Paper product with disinfecting properties |
08/06/2013 | CA2368213C Specifically targeted catalytic antagonists and uses thereof |
08/06/2013 | CA2358385C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
08/06/2013 | CA2326685C Enhancing immune responses to genetic immunization by using a chemokine |
08/01/2013 | WO2013112995A1 Influenza c virus and vaccine |
08/01/2013 | WO2013112741A1 Apoptosis signal-regulating kinase inhibitor |
08/01/2013 | WO2013112696A1 Compositions and methods for immunization against bacteria expressing a carbapenemase |
08/01/2013 | WO2013112582A1 Sandalwood oil and its uses related to clostridium infections |
08/01/2013 | WO2013112548A1 Gamma-aapeptides with potent and broad-spectrum antimicrobial activity |
08/01/2013 | WO2013110643A1 Amidine substituted beta - lactam compounds, their preparation and use as antibacterial agents |
08/01/2013 | WO2013110471A1 Means for endotoxin detoxification |
08/01/2013 | WO2013110433A1 Azaheterocyclic compounds |
08/01/2013 | WO2013110309A1 Triazolo[4,5-d]pyrimidine derivatives |
08/01/2013 | WO2013110280A1 Panobinostat for use in the treatment of hiv-1 |
08/01/2013 | WO2013082531A3 Broad spectrum influenza a neutralizing vaccines and d-peptidic compounds, and methods for making and using the same |
08/01/2013 | WO2013054866A8 Agent for preventing or treating htlv-i associated myelopathy |
08/01/2013 | WO2013048584A3 Prodrugs for treating microbial infections |
08/01/2013 | WO2012085668A3 Compounds |
08/01/2013 | WO2012061248A8 Novel specific hcv ns3 protease inhibitors |
08/01/2013 | US20130196987 Macrocyclic compounds useful as pharmaceuticals |
08/01/2013 | US20130196849 Substituted Cellulose Acetates and Uses Thereof |
08/01/2013 | US20130195960 Substituted Cellulose Acetates and Uses Thereof |
08/01/2013 | US20130195915 Influenza C Virus and Vaccine |
08/01/2013 | US20130195890 Treatment of ms with goat serum |
08/01/2013 | US20130195771 Gantrez Hydrogel With Dry Tack |
08/01/2013 | CA2862483A1 Sandalwood oil and its uses related to clostridium infections |
08/01/2013 | CA2862030A1 Apoptosis signal-regulating kinase inhibitor |
08/01/2013 | CA2857046A1 Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof |
08/01/2013 | CA2856443A1 Vaccines against clostridium difficile comprising recombinant toxins |
07/31/2013 | EP2620453A1 FUSION PROTEIN SAmB, CODING GENE AND APPLICATION THEREOF |
07/31/2013 | EP2620439A1 8-pyrazinyl-S-spiropyrimidinetrione-oxazinoquinoline derivatives as antibacterial agents |
07/31/2013 | EP2620436A1 Substituted polycyclic carbamoyl pyridone derivative prodrug |
07/31/2013 | EP2620434A1 Crystals of substituted cycloalkene derivatives |
07/31/2013 | EP2620423A1 Improved methods for preparing squalene |
07/31/2013 | EP2620162A1 Enzyme-polymer conjugate for endotoxin detoxification |
07/31/2013 | EP2620160A1 Composition for oral use |
07/31/2013 | EP2620152A1 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same |
07/31/2013 | EP2619216A1 Substituted nucleotide analogs |
07/31/2013 | EP2619215A1 Azido nucleosides and nucleotide analogs |
07/31/2013 | EP2619194A1 Fatty acid derivatives of catechins and methods of their use |
07/31/2013 | EP2618844A2 Oral composition and method of forming and using same |
07/31/2013 | EP2618843A2 Novel hiv-1 broadly neutralizing antibodies |